A Study of LY2409021 Formulations in Healthy Participants

NCT02385084 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Stopped Part B of the study no longer required due to new information on the study drug.

Conditions

Healthy

Interventions

DRUG: LY2409021

Sponsor

Eli Lilly and Company